EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Other Operating Expenses (2011 - 2026)

EyePoint (EYPT) posted Other Operating Expenses of -$82.4 million for Q1 2026, down 119.96% sequentially from $413.1 million in Q4 2025, and down 775.62% YoY from $12.2 million in Q1 2025.

Analysis

EyePoint (EYPT) Other Operating Expenses (2011 - 2026) Analysis & Trends

EyePoint has reported Other Operating Expenses for 13 years, with the latest figure at -$82.4 million in Q1 2026.

  • Quarterly Other Operating Expenses fell 775.62% year-over-year to -$82.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $272.6 million (up 254.87% YoY) and the FY2025 annual result came in at $223.1 million, up 5705.49% from the prior year.
  • Other Operating Expenses eased to -$82.4 million in Q1 2026 per EYPT's latest filing, from $413.1 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $413.1 million in Q4 2025 and troughed at -$88.6 million in Q4 2024.
  • A 5-year average of $8.1 million and a median of $765000.0 in 2024 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2024 and 2025: Other Operating Expenses sank 2421.89% in 2024, then soared 566.19% in 2025.
  • Over 5 years, Other Operating Expenses stood at $39.9 million in 2022, then plunged by 222.32% to -$48.8 million in 2023, then sank by 81.74% to -$88.6 million in 2024, then jumped by 566.19% to $413.1 million in 2025, then slumped by 119.96% to -$82.4 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered -$82.4 million, $413.1 million, and -$58.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31,000.00
Mar 31, 2026 531,000.00
Dec 31, 2025 369,000.00
Sep 30, 2025 747,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 840,000.00
Dec 31, 2024 867,000.00
Sep 30, 2024 760,000.00
Jun 30, 2024 1.45 Mn
Mar 31, 2024 765,000.00
Dec 31, 2023 1.18 Mn
Sep 30, 2023 1.68 Mn
Jun 30, 2023 7.08 Mn
Mar 31, 2023 6.38 Mn
Dec 31, 2022 30.23 Mn
Sep 30, 2022 8.04 Mn
Jun 30, 2022 9.23 Mn
Mar 31, 2022 9.09 Mn
Dec 31, 2021 18.78 Mn
Sep 30, 2021 9.81 Mn